• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌诊断中的陷阱:1791例临床结果的回顾性分析

Pitfalls in the diagnosis of prostatic cancer: retrospective review of 1791 cases with clinical outcome.

作者信息

Berney D M, Fisher G, Kattan M W, Oliver R T D, Møller H, Fearn P, Eastham J, Scardino P, Cuzick J, Reuter V E, Foster C S

机构信息

Department of Histopathology, St Bartholomew's Hospital, London, UK.

出版信息

Histopathology. 2007 Oct;51(4):452-7. doi: 10.1111/j.1365-2559.2007.02819.x.

DOI:10.1111/j.1365-2559.2007.02819.x
PMID:17880526
Abstract

AIMS

To assess the possible reasons for error in the diagnosis of prostatic cancer with available follow-up data.

METHOD AND RESULTS

A cohort of 1791 cases of prostatic cancer diagnosed in the UK between 1990 and 1996 was examined. All cases were clinically localized at presentation, treated by non-curative methods and detailed follow-up was available. A panel of genitourinary pathologists reviewed the pathology of all cases. One hundred and thirty-three (7.5%) of cases were reassigned to a non-malignant diagnosis. Where possible, reasons for the initial diagnosis were given. These included severe atrophy, inflammatory induced atypia, sclerosing adenosis, atypical adenomatous hyperplasia and basal cell hyperplasia. Follow-up of these patients showed an extremely low death rate from prostatic cancer: lower than that for the Gleason combined score of five or less tumours diagnosed in this series.

CONCLUSIONS

Many morphological entities potentially mimic prostatic cancer and may be responsible for misdiagnosis in routine specimens. Continuing education in prostatic morphology and immunohistochemistry may have helped reduce this error rate.

摘要

目的

利用现有随访数据评估前列腺癌诊断错误的可能原因。

方法与结果

对1990年至1996年间在英国诊断出的1791例前列腺癌病例进行了研究。所有病例在初诊时均为临床局限性病变,采用非根治性方法治疗,并可获得详细的随访资料。一组泌尿生殖病理学家对所有病例的病理进行了复查。133例(7.5%)病例被重新诊断为非恶性病变。在可能的情况下,给出了初始诊断的原因。这些原因包括严重萎缩、炎症性非典型增生、硬化性腺病、非典型腺瘤样增生和基底细胞增生。对这些患者的随访显示,前列腺癌死亡率极低:低于本系列中诊断出的Gleason总分5分及以下肿瘤的死亡率。

结论

许多形态学实体可能酷似前列腺癌,可能是常规标本误诊的原因。前列腺形态学和免疫组织化学方面的继续教育可能有助于降低这一错误率。

相似文献

1
Pitfalls in the diagnosis of prostatic cancer: retrospective review of 1791 cases with clinical outcome.前列腺癌诊断中的陷阱:1791例临床结果的回顾性分析
Histopathology. 2007 Oct;51(4):452-7. doi: 10.1111/j.1365-2559.2007.02819.x.
2
Mesonephric remnant hyperplasia involving prostate and periprostatic tissue: findings at radical prostatectomy.前列腺及前列腺周围组织中肾间叶残留增生:根治性前列腺切除术中的发现。
Am J Surg Pathol. 2011 Jul;35(7):1054-61. doi: 10.1097/PAS.0b013e318218df97.
3
Histopathologic False-positive Diagnoses of Prostate Cancer in the Age of Immunohistochemistry.免疫组织化学时代前列腺癌的组织病理假阳性诊断。
Am J Surg Pathol. 2019 Mar;43(3):361-368. doi: 10.1097/PAS.0000000000001202.
4
The differential diagnosis of prostatic carcinoma. Its distinction from premalignant and pseudocarcinomatous lesions of the prostate gland.前列腺癌的鉴别诊断。它与前列腺癌前病变及假癌性病变的区分。
Am J Clin Pathol. 1994 Jan;101(1):48-64. doi: 10.1093/ajcp/101.1.48.
5
A case showing sclerosing adenosis and an unusual form of basal cell hyperplasia of the prostate.
Am J Surg Pathol. 1989 Oct;13(10):866-72. doi: 10.1097/00000478-198910000-00006.
6
Atypical adenomatous hyperplasia (adenosis) of the prostate.前列腺非典型腺瘤样增生(腺病)
J Urol. 2012 Dec;188(6):2371-2. doi: 10.1016/j.juro.2012.09.058. Epub 2012 Sep 20.
7
The spectrum of morphology in non-neoplastic prostate including cancer mimics.非肿瘤前列腺的形态学谱,包括癌类似物。
Histopathology. 2012 Jan;60(1):41-58. doi: 10.1111/j.1365-2559.2011.04000.x.
8
Ten-year follow-up of atypical small acinar hyperplasia cases diagnosed by initial prostate biopsy.经初次前列腺活检诊断的非典型小腺泡增生病例的十年随访。
BMC Cancer. 2025 May 28;25(1):964. doi: 10.1186/s12885-025-14366-8.
9
Sclerosing adenosis of the prostate gland. A clinicopathological and immunohistochemical study of 11 cases.
Am J Surg Pathol. 1991 Dec;15(12):1171-80. doi: 10.1097/00000478-199112000-00008.
10
Prostatic adenocarcinoma with atrophic features: malignancy mimicking a benign process.具有萎缩特征的前列腺腺癌:酷似良性过程的恶性肿瘤。
Am J Surg Pathol. 1997 Aug;21(8):931-5. doi: 10.1097/00000478-199708000-00007.

引用本文的文献

1
Prostate sclerosing adenopathy: A clinicopathological and immunohistochemical study of twelve patients.前列腺硬化性腺病:12例患者的临床病理及免疫组化研究
World J Clin Cases. 2022 Jun 26;10(18):6009-6020. doi: 10.12998/wjcc.v10.i18.6009.
2
Three-dimensional architecture of common benign and precancerous prostate epithelial lesions.常见良性和癌前前列腺上皮病变的三维结构。
Histopathology. 2019 Jun;74(7):1036-1044. doi: 10.1111/his.13848. Epub 2019 Apr 21.
3
Histopathologic False-positive Diagnoses of Prostate Cancer in the Age of Immunohistochemistry.
免疫组织化学时代前列腺癌的组织病理假阳性诊断。
Am J Surg Pathol. 2019 Mar;43(3):361-368. doi: 10.1097/PAS.0000000000001202.
4
Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome.以前列腺癌死亡为结局对当代前列腺癌分级系统进行验证。
Br J Cancer. 2016 May 10;114(10):1078-83. doi: 10.1038/bjc.2016.86. Epub 2016 Apr 21.
5
Multimodal microscopy for automated histologic analysis of prostate cancer.多模态显微镜在前列腺癌自动组织学分析中的应用。
BMC Cancer. 2011 Feb 9;11:62. doi: 10.1186/1471-2407-11-62.
6
Hsp-27 expression at diagnosis predicts poor clinical outcome in prostate cancer independent of ETS-gene rearrangement.诊断时热休克蛋白27(Hsp-27)的表达可预测前列腺癌的不良临床结局,且独立于ETS基因重排。
Br J Cancer. 2009 Oct 6;101(7):1137-44. doi: 10.1038/sj.bjc.6605227. Epub 2009 Aug 25.
7
Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype.男性携带BRCA1和BRCA2基因突变者患前列腺癌后,其表型更具侵袭性。
Br J Cancer. 2008 Jan 29;98(2):502-7. doi: 10.1038/sj.bjc.6604132. Epub 2008 Jan 8.